No Data
No Data
Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ): Director and General Manager Qian Shuangxi resigns.
Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ) announced on July 24th that the Board of Directors received the written resignation report of Mr. Qian Shuangxi, director and general manager of the company, on July 24th, 2024. Due to job transfer, Mr. Qian Shuangxi applied to resign from the fifth board of directors and general manager of the company, as well as the nomination committee and strategic committee of the fifth board of directors. After resigning, he will no longer hold any other positions in the company. Mr. Qian Shuangxi's original term of office was from January 3rd, 2024 to January 2nd, 2027.
As of July 19th, the number of shareholders in Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. (300534.SZ) was 29,642.
On July 22, Gelunhui reported that Gansu Longshenrongfa Pharmaceutical Industry (stock code 300534.SZ) stated on the investor interaction platform that, according to data provided by China Securities Depository and Clearing Co., Ltd., as of July 19, 2024, the number of shareholders in the company was 29,642.
As of July 10, 2024, the number of shareholders in Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ) was 31,236.
On July 11th, Gelunhui reported that as of July 10, 2024, the number of shareholders of Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ) provided by China Securities Depository and Clearing Co., Ltd. was 31,236.
As of June 7, 2024, the number of shareholders of Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ) was 30,383.
On June 12th, Gelunhui reported that as of June 7, 2024, the number of shareholders of Gansu Longshen Rongfa Pharmaceutical Co., Ltd. (stock code 300534.SZ) reached 30,383.
Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ): Its holding subsidiary has passed the review of specialized, special and new small and medium-sized enterprises in Gansu Province.
On June 6th, GeLong Hui reported that Gansu Longshenrongfa Pharmaceutical Co., Ltd. (300534.SZ), the controlling subsidiary of which, Gansu Pu'an Pharmaceutical Co., Ltd., recently received an announcement from the Gansu Provincial Department of Industry and Information Technology via the Industrial and Information Technology Bureau of Liangzhou District, Wuwei City, regarding the announcement of the list of small and medium-sized enterprises and verified enterprises that were awarded the 'specialized, special, and new' title in Gansu Province in 2024. Pu'an Pharmaceutical passed the review for small and medium-sized enterprises with 'specialized, special, and new' status in Gansu Province, and the valid period is three years from the announcement date.
Longshen Rongfa (300534.SZ) plans to pay 0.2 yuan for every 10 shares in 2023, excluding interest on June 6
Longshen Rongfa (300534.SZ) announced that the company plans to distribute 0.2 for every 10 shares to all shareholders in 2023...
No Data